CRC “A. M. and A. Migliavacca” Center for Liver Disease, Department of Pathophysiology and Transplantation, University of Milan, Italy
Disclosure(s): AbbVie: Speaking/teaching fees/advisory committee/review panel; Aligos Therapeutics: Speaking/teaching fees/advisory committee/review panel; Alnylam Pharmaceuticals: Speaking/teaching fees/advisory committee/review panel; Antios Therapeutics: Speaking/teaching fees/advisory committee/review panel; Arrowhead Pharmaceuticals: Speaking/teaching fees/advisory committee/review panel; Bristol Myers Squibb: Speaking/teaching fees/advisory committee/review panel; Eiger Biopharmaceuticals: Speaking/teaching fees/advisory committee/review panel; Gilead Sciences, Inc.: Speaking/teaching fees/advisory committee/review panel; GSK: Speaking/teaching fees/advisory committee/review panel; Janssen: Speaking/teaching fees/advisory committee/review panel; Merck Sharp & Dohme: Speaking/teaching fees/advisory committee/review panel; MYR GmbH: Speaking/teaching fees/advisory committee/review panel; Roche: Speaking/teaching fees/advisory committee/review panel; Spring Bank Pharmaceuticals: Speaking/teaching fees/advisory committee/review panel